SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-08-001366
Filing Date
2008-02-14
Accepted
2008-02-13 20:23:45
Documents
8
Period of Report
2008-02-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 OPEXA THERAPEUTICS, INC. 8-K a5610481.htm 8-K 25835
2 EXHIBIT 1.1 a5610481ex1_1.htm EX-1.1 216149
3 EXHIBIT 4.3 a5610481ex4_3.htm EX-4.3 149717
4 EXHIBIT 4.4 a5610481ex4_4.htm EX-4.4 127932
5 EXHIBIT 4.5 a5610481ex4_5.htm EX-4.5 144167
6 EXHIBIT 99.1 a5610481ex99_1.htm EX-99.1 10509
7 LOGO logo1.jpg GRAPHIC 2983
8 PRESS RELEASE LOGO prlogo.jpg GRAPHIC 5599
  Complete submission text file 0001157523-08-001366.txt   688214
Mailing Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381
Business Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 08607457
SIC: 2834 Pharmaceutical Preparations